You are entering a specialized publication that is part of the LLC "ORGANOSIN LTD" website and is intended exclusively for medical, pharmaceutical and/or rehabilitation professionals (hereinafter referred to as medical/pharmaceutical professionals) and contains professional specialized information about medicines, including prescription drugs, in particular about their name, characteristics, methods of application, therapeutic properties, possible side effects, possible contraindications and other professional specialized information.
Information about medicines, including prescription drugs of LLC "ORGANOSIN LTD", is intended solely for informational purposes and is not a guide for self-diagnosis or treatment.
Do you confirm that you have read this restriction on obtaining information and are you a medical/pharmaceutical professional?
EZOLONG®
EZOLONG®
Type of the medical product
Antisecretory parenteral drugForm of release
Powder for solution for injection or infusionComposition
1 vial contains esomeprazole sodium 42,60 mg, equivalent to esomeprazole 40 mg; disodium edetate (Trilon B), sodium hydroxidePurpose
Adults:∙ Antisecretory therapy when it is impossible to use the oral route of administration:
- gastroesophageal reflux disease in patients with esophagitis and / or severe reflux symptoms;
- treatment of gastric ulcers associated with the treatment of nonsteroidal anti-inflammatory drugs (NSAIDs);
- prevention of gastric and duodenal ulcers associated with NSAID therapy in at-risk patients.
∙ Short-term maintenance of hemostasis and prevention of recurrent bleeding in patients after endoscopic treatment of acute bleeding due to the ulcer of stomach or duodenum.
Children from 1 to 18 years:
∙ Antisecretory therapy when it is impossible to use the oral route of administration:
- gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and / or severe reflux symptoms.
Instructions
